Concepedia

Noa G. Holtzman

NG

14

Publications

235

Citations

11

H-Index

2015

Active since

Affiliations

University of Maryland, Baltimore(Current)

National Institutes of Health

Center for Cancer Research

National Cancer Institute

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Noa G. Holtzman is an author at University of Maryland, Baltimore specializing in medicine, immunology, and hematology.

ORCID

Top concepts

Publications per year

2015–2024

14

Publications

14

Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy

Rick Y. Lin, Anthony D. Anderson, Yoichiro Natori et al. · Blood Advances · 2024 · 27 citations · Full text

The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma

Forat Lutfi, Noa G. Holtzman, Ankit Kansagra et al. · British Journal of Haematology · 2021 · 25 citations · Full text

Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma

Forat Lutfi, Noa G. Holtzman, Jonathan Siglin et al. · British Journal of Haematology · 2020 · 23 citations · Full text

Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia

Sahar Rostami-Mansoor, Noa G. Holtzman, Ashkan Emadi · Case Reports in Hematology · 2015 · 21 citations · Full text

, , +7

A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease

Lauren M. Curtis, Alen Ostojić, David Venzon et al. · Blood · 2020 · 20 citations · Full text

Rows per page

1–5 of 14